Study Stopped
Poor accruals
EMST and Swallowing in Long-Term Survivors of HNCA
Effects of Expiratory Muscle Strength Training (EMST) on Long-Term Swallowing Dysfunction in Persons With Head and Neck Cancer (HNCA) Post Irradiation (RT)
1 other identifier
interventional
6
1 country
2
Brief Summary
This study is a randomized trial examining the impact of expiratory muscle strength training (EMST) on oral intake, swallowing function, and swallow-related quality of life in persons treated for cancer of the head and neck (HNCA) with radiation therapy or chemoradiotherapy (RT/CRT) at least 5 years previously.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2018
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 10, 2018
CompletedFirst Submitted
Initial submission to the registry
June 1, 2019
CompletedFirst Posted
Study publicly available on registry
June 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 4, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 4, 2024
CompletedDecember 6, 2024
December 1, 2024
5.7 years
June 1, 2019
December 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Level of Oral Intake (number)
Change in Food Level and Drink Level on International Dysphagia Diet Standardisation Initiative (IDDSI) scale will be calculated from baseline to post-treatment. IDDSI scale rates the level of liquid or food that the person can eat. Scale values range from 0 to 7, with higher values indicating better outcome (greater ability to eat).
8 weeks
Maximum Expiratory Pressure (MEP) cm H20
Change in maximum expiratory pressure level will be calculated from baseline to post-treatment.
8 weeks
Extent of hyoid movement (mm)
From Videofluoroscopic Swallow Studies (VFSS), the change in extent of hyoid movement in mm will be determined from baseline to post-treatment.
8 weeks
Upper esophageal sphincter (UES) opening width (mm)
From Videofluoroscopic Swallow Studies (VFSS), the change in width of UES opening width in mm will be determined from baseline to post-treatment.
8 weeks
Presence of pharyngeal residue (dichotomous)
From Videofluoroscopic Swallow Studies (VFSS), the presence of residue in the pharynx (yes or no) will be determined from baseline to post-treatment.
8 weeks
Penetration-Aspiration Scale rating (number)
From Videofluoroscopic Swallow Studies (VFSS), change in the Penetration-Aspiration Scale (PAS) score will be determined from baseline to post-treatment. Penetration-Aspiration Scale is an 8-point ordinal rating scale that rates the depth to which food or liquid invades the airway. Values range from a minimum of 1 to a maximum of 8; higher values represent worse outcome (i.e. greater depth of invasion into the airway)
8 weeks
Timing of Aspiration (category)
From Videofluoroscopic Swallow Studies (VFSS), timing of aspiration will be determined from baseline to post-treatment. Timing is identified as a category, either before, during, or after.
8 weeks
Other Outcomes (2)
Eating Assessment Tool (EAT-10) (number)
8 weeks
M.D. Anderson Dysphagia Inventory (MDADI) (number)
8 weeks
Study Arms (2)
Expiratory Muscle Strength Training
EXPERIMENTALPatients randomized to the EMST arm will use the EMST150 device as packaged, i.e. following package instructions
Pharyngeal Muscle Strengthening Exercises
ACTIVE COMPARATORPatients randomized to Standard Care will receive swallowing exercises designed to strengthen muscles that contribute to pharyngeal phase motor events and increase structural range of motion
Interventions
8 weeks of EMST at 75% maximum expiratory pressure (MEP)
8 weeks of exercises designed to increase pharyngeal muscle strength for swallowing
Eligibility Criteria
You may qualify if:
- Subject was treated for cancer in the oral cavity, oropharynx, hypopharynx, larynx, or for an unknown primary at least 5 years prior to enrollment. Subjects may have had surgery as long as a minimum dose of 50 Gy of radiation was part of the treatment;
- Subject must have a current swallow complaint or impairment; these include but are not limited to reduced oral intake, perceived difficulty with bolus transport (e.g. feeling of food sticking in throat); aspiration on various bolus consistencies;
- Ability to follow directions and engage in a program of rehabilitation
You may not qualify if:
- the subject's swallowing problems are unrelated to treatment for HNCA (e.g. cognitive impairment, history of stroke);
- the subject presents with contraindications for EMST as specified in the EMST150 package insert unless cleared for participation by the subject's physician. These conditions include untreated hypertension, untreated gastroesophageal reflux diseas, recent stroke, lung disease, and pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Wisconsin, Milwaukeelead
- Froedtert Hospitalcollaborator
- Medical College of Wisconsincollaborator
Study Sites (2)
University of Wisconsin Milwaukee
Milwaukee, Wisconsin, 53211, United States
Froedtert Hospital
Milwaukee, Wisconsin, 53226, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara Pauloski, Ph.D.
University of Wisconsin, Milwaukee
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Researchers assessing the outcomes will not know the arm to which the subject was randomized.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 1, 2019
First Posted
June 5, 2019
Study Start
September 10, 2018
Primary Completion
June 4, 2024
Study Completion
June 4, 2024
Last Updated
December 6, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share